Titre : | Program factors and treatment outcomes in drug dependance treatment : an examination using meta-analysis |
Titre traduit : | (Les facteurs liés aux résultats d'un programme de traitement de la dépendance : méta-analyse) |
Auteurs : | M. L. PRENDERGAST ; D. PODUS ; E. CHANG |
Type de document : | Périodique |
Année de publication : | 2000 |
Format : | 1931-1965 / tabl. |
Note générale : |
Substance Use and Misuse, 2000, 35, (12/14), 1931-1965 |
Langues: | Anglais |
Discipline : | EPI (Epidémiologie / Epidemiology) |
Mots-clés : |
Thésaurus mots-clés TRAITEMENT ; EFFICACITE ; PROGRAMME ; DEPENDANCE ; EVALUATION |
Résumé : |
ENGLISH : In comparison with studies of client characteristics and treatment processes, limited research has been conducted on how program features of drug dependence treatment programs may affect client outcomes. Of particular interest are those characteristics of programs that may have a clinically significant impact on outcomes and that are amenable to change within programs. This study examines the impact of various program factors on client outcomes using data from a meta-analysis of drug dependence effectiveness studies (n = 143). Because of heterogeneity among studies, the data are analyzed in terms of type of outcome variable (drug use and crime), type of design (single-group and treatment-comparison group), and type of treatment (methadone maintenance, therapeutic communities, outpatient drug free, and detoxification). For the more valid treatment-comparison group studies, the weighted mean effect size was 0.29 for drug use outcomes and 0.17 for crime out-comes. Program factors found to be significantly correlated with effect size in one or more modalities were decade of treatment, researcher involvement in treatment delivery, maturity of the program, counselor/client ratio, treatment implementation, treatment exposure, and methadone dosage. (Editor's abstract.) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 49 |
Affiliation : |
UCLA Drug Abuse Research Ctr, 1640 Sepulveda blvd, suite 200, Los Angeles, CA 90025. E-mail : mlp@ucla.edu Etats-Unis. United States. |
Numéro Toxibase : | 403467 |
Centre Emetteur : | 04 CIRDD-51 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil